Recent

% | $
Quotes you view appear here for quick access.

Neurocrine Biosciences Inc. Message Board

  • pharmaherocc pharmaherocc Feb 1, 2012 8:05 AM Flag

    (DSCO) FDA DECISION 6 MARCH=5 BAGGER (Mcap 53 M) !!!

    TIME TO LOAD UP THE VERY CHEAP SHARES OF THIS ALMOST UNKNOW LOW FLOAT MONSTER .MARKET CAP OF 53 M IS A BIG JOKE .GLTA

    Surfaxin has $ 500 M market potential once approved it will push DSCO into Double Digits easily .

    DSCO is significantly at current levels .FDA runup could start any time now which will drive this LOW FLOAT MONSTER to 4-5 Dollars .

    GREAT BUYING OPPORTUNITY HERE ....


    Discovery Labs (DSCO)

    Market Cap : $ 53 M
    Cash : $ 15.4 M
    Price : 2.18

    Shares Out : 24 .5 M


    Discovery Laboratories (DSCO) – Decision Date: March 6, 2012

    Drug: Surfaxin – Treatment: prevention of respiratory distress syndrome in premature infants.

    Discovery Labs also has a few drugs in its pipeline. Aerosurf is in Phase 2 for the treatment of moderate respiratory distress syndrome. Liquid KL4 Surfactant is in Phase 2 to treat a wide range of respiratory diseases. Aerosolized KL4 Surfactant is in early development to treat acute lung injury and bronchiectasis. The same drug is in Phase 2 for treating cystic fibrosis.




















    23r23rdr32d32d32dr32r

 
NBIX
43.37-0.3100(-0.71%)Apr 24 4:00 PMEDT